US 12,419,989 B2
Solid solution compositions comprising cannabidiols
Ethan G. Sherman, Jacksonville, FL (US); Wei Chen, St. Johns, FL (US); and Denise E. Guenther, Jacksonville, FL (US)
Assigned to Medtronic Xomed, Inc., Jacksonville, FL (US)
Filed by Medtronic Xomed, Inc., Jacksonville, FL (US)
Filed on Nov. 17, 2023, as Appl. No. 18/513,436.
Application 18/513,436 is a continuation of application No. 17/360,691, filed on Jun. 28, 2021, granted, now 11,839,693.
Application 17/360,691 is a continuation of application No. 16/706,209, filed on Dec. 6, 2019, granted, now 11,045,577, issued on Jun. 29, 2021.
Application 16/706,209 is a continuation of application No. 15/954,471, filed on Apr. 16, 2018, granted, now 10,517,986, issued on Dec. 11, 2019.
Application 15/954,471 is a continuation of application No. 14/962,493, filed on Dec. 8, 2015, abandoned.
Prior Publication US 2024/0082456 A1, Mar. 14, 2024
This patent is subject to a terminal disclaimer.
Int. Cl. A61L 24/00 (2006.01); A61F 13/20 (2006.01); A61K 9/00 (2006.01); A61L 2/00 (2006.01); A61L 15/22 (2006.01); A61L 24/04 (2006.01); A61L 24/08 (2006.01); A61L 31/04 (2006.01); A61L 31/14 (2006.01); A61L 31/16 (2006.01); B65B 55/16 (2006.01); B65B 63/08 (2006.01)
CPC A61L 24/0042 (2013.01) [A61F 13/2005 (2013.01); A61K 9/0043 (2013.01); A61L 2/0029 (2013.01); A61L 15/225 (2013.01); A61L 24/0015 (2013.01); A61L 24/0036 (2013.01); A61L 24/043 (2013.01); A61L 24/08 (2013.01); A61L 31/042 (2013.01); A61L 31/146 (2013.01); A61L 31/148 (2013.01); A61L 31/16 (2013.01); B65B 55/16 (2013.01); B65B 63/08 (2013.01); A61L 2202/24 (2013.01); A61L 2300/232 (2013.01); A61L 2300/404 (2013.01); A61L 2400/04 (2013.01)] 20 Claims
 
1. An article, comprising:
a water-absorbent, porous, dissolvable sponge derived from a mixture of polysaccharides consisting of chitosan and a plurality of cellulosic polysaccharides, and optionally one or more other polysaccharides distinct from chitosan, the plurality of cellulosic polysaccharides having different number average molecular weights enabling control of mechanical features of the dissolvable sponge to form a sponge that is hydratable, has stenting capabilities to hold open an anatomical location, and exhibits a wet or dry compression strength of at least 20 grams according to the Compression Test and a dissolution rate of greater than or equal to 1 day according to the Dissolution Test.